PREZIOSO, CARLA
 Distribuzione geografica
Continente #
AS - Asia 352
NA - Nord America 205
EU - Europa 75
AF - Africa 1
Totale 633
Nazione #
US - Stati Uniti d'America 184
SG - Singapore 169
CN - Cina 101
TR - Turchia 75
IT - Italia 38
DE - Germania 23
CA - Canada 20
FI - Finlandia 5
HK - Hong Kong 4
NL - Olanda 4
ES - Italia 2
GB - Regno Unito 2
IR - Iran 1
KR - Corea 1
MX - Messico 1
PH - Filippine 1
RU - Federazione Russa 1
SC - Seychelles 1
Totale 633
Città #
Singapore 53
Santa Clara 49
San Mateo 39
Kocaeli 34
Toronto 19
Dallas 17
Assago 16
Guangzhou 15
Rome 15
Shanghai 14
Shenzhen 11
Ashburn 9
Beijing 9
Frankfurt am Main 8
Wilmington 7
Lawrence 6
Princeton 6
West Jordan 6
Helsinki 5
Munich 5
Hong Kong 4
Jiaxing 3
Los Angeles 3
Seattle 2
Wuxi 2
Xi'an 2
Alexandrov 1
Cantalupo In Sabina 1
Chandler 1
Cosenza 1
Council Bluffs 1
Dongyang 1
Fort Worth 1
Foshan 1
Fuzhou 1
Gebze 1
Granada 1
Huzhou 1
Irving 1
Jining 1
LaSalle 1
Leicester 1
Manila 1
Mexico 1
Nanjing 1
Perugia 1
Peschiera 1
Peterborough 1
Putian 1
Rockville 1
Rui'an 1
Seoul 1
Shijiazhuang 1
Taizhou 1
Wuhan 1
Wuhu 1
Totale 389
Nome #
d-Mannose Treatment neither Affects Uropathogenic Escherichia coli Properties nor Induces Stable FimH Modifications 44
COS-7-based model: methodological approach to study John Cunningham virus replication cycle 42
Cutaneous candidiasis caused by Candida albicans in a young non-immunosuppressed patient: an unusual presentation 42
d-Mannose Treatment neither Affects Uropathogenic Escherichia coli Properties nor Induces Stable FimH Modifications. 38
SARS-CoV-2: Comparative analysis of different RNA extraction methods 35
Merkel Cell Polyomavirus (MCPyV) in the Context of Immunosuppression: Genetic Analysis of Noncoding Control Region (NCCR) Variability Among a HIV-1-Positive Population 34
COS-7 and SVGp12 Cellular Models to Study JCPyV Replication and MicroRNA Expression after Infection with Archetypal and Rearranged-NCCR Viral Strains 19
Evaluation of redox state alterations in influenza A virus-infected neuronal cells: involvement in neurotropism. 17
Detection analysis and study of genomic region variability of JCPyV, BKPyV, MCPyV, HPyV6, HPyV7 and QPyV in the urine and plasma of HIV-1-infected patients 15
Characterization of Human Polyomavirus JC (JCPyV) infection in Human Neuroblastoma SH-SY5Y cells and evaluation of redox state during viral replication 15
Functional Domains of the Early Proteins and Experimental and Epidemiological Studies Suggest a Role for the Novel Human Polyomaviruses in Cancer 14
Genetic Diversity of the Noncoding Control Region of the Novel Human Polyomaviruses 13
High prevalence of Merkel cell polyomavirus is associated with dysregulation in transcript levels of TLR9 and type I IFNs in a large cohort of CF patients from the Italian (Lazio) reference center for cystic fibrosis 13
Evaluation of merkel cell polyomavirus DNA in tissue samples from italian patients with diagnosis of MCC 13
SARS-CoV-2 epidemiological surveillance of healthcare professionals working in an inpatient rehabilitation facility 13
HPyV6 and HPyV7 in urine from immunocompromised patients 12
Detection of human neurotropic JCPyV DNA sequence in pediatric anaplastic xanthoastrocytoma 12
John Cunningham virus: an overview on biology and disease of the etiological agent of the progressive multifocal leukoencephalopathy 12
Dynamic changes of mmp-9 plasma levels correlate with jvc reactivation and immune activation in natalizumab-treated multiple sclerosis patients 12
Efficient propagation of archetype JC polyomavirus in COS-7 cells: evaluation of rearrangements within the NCCR structural organization after transfection 12
Identification and Antimicrobial Susceptibility Testing of Microorganisms From Positive blood Cultures by a Combined Lysis-centrifugation Method with MALDI-TOF MS and VITEK2 System 11
Common microbial genital infections and their impact on the innate immune response to HPV in cervical cells 11
Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment 11
BK virus and transplantation 11
Structural analysis of merkel cell polyomavirus (MCPyV) viral capsid protein 1 (VP1) in HIV-1 infected individuals 11
Detection of Quebec polyomavirus DNA in samples from different patient groups 10
Reply to Henriksen, S.; Rinaldo, C.H. Should SVGp12 be used for JC polyomavirus studies? comment on “prezioso et al. COS-7 and SVGp12 cellular models to study JCPyV replication and microRNA expression after infection with archetypal and rearranged-NCCR viral strains. Viruses 2022, 14, 2070 10
The inhibition of DNA viruses by the amphibian antimicrobial peptide temporin G. A virological study addressing HSV-1 and JPCyV 10
Merkel cell polyomavirus and Merkel cell carcinoma 10
Detection of Merkel cell polyomavirus (mcpyv) dna and transcripts in Merkel cell carcinoma (mcc) 10
COVID-19. Update of the Italian situation 10
Regulation of transcriptional activity of Merkel cell polyomavirus large T-Antigen by PKA-mediated phosphorylation 10
Merkel cell polyomavirus DNA detection in respiratory samples: study of a cohort of patients affected by cystic fibrosis 9
Kidney graft failure induced by BKPyV replication despite a strong reduction of the immunosuppressive therapy 9
Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis? 9
Stillbirth and fetal capillary infection by SARS-CoV-2 9
Risk Assessment of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients during 1 Year of Ocrelizumab Treatment 9
Polyomaviruses shedding in stool of patients with hematological disorders: detection analysis and study of the non-coding control region’s genetic variability 8
The "Three Italy" of the COVID-19 epidemic and the possible Involvement of SARS-CoV-2 in triggering complications other than pneumonia 8
Increased prevalence of Human Polyomavirus JC viruria in Chronic Inflammatory Rheumatic Diseases patients in treatment with anti-TNF α: a 18 month follow-up study 8
JC virus-DNA detection is associated with CD8 fffector accumulation in peripheral blood of patients with multiple sclerosis under natalizumab treatment, independently from JC virus serostatus 8
Role of virus-induced host cell epigenetic changes in cancer 8
KI and WU polyomavirus in respiratory samples of sars‐cov‐2 infected patients 8
JCPyV NCCR analysis in PML patients with different risk factors: Exploring common rearrangements as essential changes for neuropathogenesis 8
JC polyomavirus. A short review of its biology, its association with progressive multifocal leukoencephalopathy, and the diagnostic value of different methods to manifest its activity or presence 7
Effect of Cigarette Smoking on Clinical and Molecular Endpoints in COPD Patients 7
Prevalence of MCPyV, HPyV6, HPyV7 and TSPyV in Actinic Keratosis Biopsy Specimens 6
Antibacterial and Anti-Influenza Activities of N-Heterocyclic Carbene–Gold Complexes 5
The effect of Torque Teno Virus (TTV) Infection on Clinical Outcomes, Genomic Integrity, and Mortality in COPD Patients 5
Laboratory Automation in Microbiology: Impact on Turnaround Time of Microbiological Samples in COVID Time 5
Correlation between Chest Computed Tomography Score and Laboratory Biomarkers in the Risk Stratification of COVID-19 Patients Admitted to the Emergency Department 5
Role of miR-9 in Modulating NF-κB Signaling and Cytokine Expression in COVID-19 Patients 5
Totale 698
Categoria #
all - tutte 10.079
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.079


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/202149 0 0 0 3 2 1 1 1 2 1 34 4
2021/202270 0 18 20 1 0 0 12 6 0 12 1 0
2022/202342 19 0 2 2 1 0 0 0 5 11 2 0
2023/2024137 1 0 0 4 7 3 0 38 8 10 17 49
2024/2025399 34 70 48 11 33 49 34 24 84 12 0 0
Totale 698